HDL-apoAI gene expression and its kinetics in vivo
HDL-apoAI gene expression and its kinetics in vivo
批准号:
04671503
负责人:
SAKU Keijiro
金额:
$0.9万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (C)
财政年份:
1992
资助国家:
日本
项目状态:
已结题
起止时间:
1992 至 1993
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The metabolic turnover of HDL-apo AI has been studied in order to know the mechanism of low and high plasma HDL levels.1) We attempted here to determine the kinetic parameters (turnover) of HDL apo AI in normal Japanese White (control) rabbits, with or without cholesterol, probucol and pravastatin feeding. ^<125>l-labeled HDL was injected intraveneously and blood samples were taken periodically for 6 days. Kinetic parameters were calculated from the apo AI specific radioactivity decay curves. We found that the apo AI fractional catabolic rates (FCR) in rabbits fed pravastatin with Ch (group 1) were significantly less than those in rabbits fed pravastatin plus probucol with Ch (group 2) (0.546(〕SY.+-.〔)0.017 /day vs. 0.730(〕SY.+-.〔)0.126 /day, p<0.05), while the synthetic rates (SR) of apo AI was lower in group 2 than in group 1 (14.76(〕SY.+-.〔)1.71 mg/kg/day vs. 11.21(〕SY.+-.〔)2.38 mg/kg/day.respectively, p<0.1) . These data indicate that pravastatin and probucol have different effects … More on HDL-apo AI kinetics in a diet which includes cholesterol. The addition of pravastatin to probucol did not enhance HDL metabolism in this expermental models, but rather reduce the synthesis of Apo AI.Total RNA was isolated from rabbit intestine under various conditions as stated above. Compared to findings in control rabbits, probucol or pravastatin treated rabbits showed no changes in mRNA level of apo AI.2) In vivo conversion of recombinant human proapoprotein AI (rh-Met-proapo AI) from E.coli to apo AI was also investigated in rabbits in vivo. It was found that the radioactivity of rh-Met-proapo AI migrated to more acidic isoproteins, the conversion was complete within 24 hours. Thus, a) the proteolytic cleavage of proapo AI is an extracellular event, b) the converting enzyme from rabbits is functional for human proapo AI processing, and c) the injection of rh-Met-proapo AI into rabbits facilities understanding of the early events of HDL biogenesis in rabbits.3) In vivo kinetics of lipoprotein(a) [Lp(a)] were also investigated in homozygous Watanabe heritable hyperlipidemic (WHHL) rabbits, an animal model of familial hypercholesterolemia, and in normolipidemic Japanese White rabbits (controls). The fractional catabolic rates (FCRs) of both Lp(a) and LDL (1.355(〕SY.+-.〔)0.189 pools per day and 1.278(〕SY.+-.〔)0.397 pools per day, respectively) in the WHHL rabbits were significantly (p<0.005) smaller than those in the control rabbits (2-008(〕SY.+-.〔)0.083 pools per day and 2.855(〕SY.+-.〔)0.759 pools per day, respectively) . Our data storongly suggest that Lp(a) clearance is not entirely dependent upon LDL receptors and may be mediated by some other mechanisms.4) We found six types of apo AI variants. They were radiolabeled and injected into rabbits as above. We found no peculiar pathway for apo AI variants compated to the kinetics of native apo Al(Al_3) . Less
期刊论文(43)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Saku,K.et al: "Combined therapy with probucol and pravastatin in hypercholesterolemia." European Journal of Clinical Pharmacology. 44. 535-539 (1993)
Saku,K.等人:“普罗布考和普伐他汀联合治疗高胆固醇血症。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Bai,H.,Saku,K.et al: "Polymorphic site study at codon 347 of apolipoprotein A-IV in a Japanese population" Biochimica et Biophysica Acta. 1174. 279-281 (1993)
Bai,H.,Saku,K.等人:“日本人群中载脂蛋白 A-IV 密码子 347 的多态性位点研究”Biochimica et Biophysicala Acta。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Saku, K.et al: "In vivo conversion of recombinant human proapolipoprotein AI to apolipoprotein AI." Biochimica et Biophysica Acta.1217. 29-30 (1994)
Saku, K.等人:“重组人载脂蛋白原 AI 体内转化为载脂蛋白 AI。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Bai,H.,Saku,K.et al: "Polymorphic site study at dodon 347 of apolipoprotein A-IV in a Japanese population." Biochimica et Biophysica Acta. 1174. 279-281 (1993)
Bai,H.,Saku,K.等人:“日本人群中载脂蛋白 A-IV dodon 347 的多态性位点研究。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Okura,Y.,Saku,K.et al: "Serum lipoprotein(a) in maintenance hemodialysis patients" Nephron. (1993)
Okura,Y.,Saku,K.等人:“维持性血液透析患者的血清脂蛋白(a)”肾单位。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 22 条
New diagnostic and therapeutic strategies for atherosclerosis using newly developed apolipoprotein A-I mimetic peptide
-
批准号:24591123
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.24万
-
财政年份:2012
-
负责人:SAKU Keijiro
-
依托单位:
Possibility of drug discovery : Development of new peptide type of reconstituted HDL
-
批准号:21590960
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.75万
-
财政年份:2009
-
负责人:SAKU Keijiro
-
依托单位:
Advanced medical technology on cardiovascular disease- Elucidation of the molecular mechanism and the application on various pathological conditions for the establishment of HDL therapy
-
批准号:18590826
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.56万
-
财政年份:2006
-
负责人:SAKU Keijiro
-
依托单位:
Therapeutic strategy for atherosclerosis targeting for CETP
-
批准号:12670712
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:SAKU Keijiro
-
依托单位:
Quality, function and genetic assessments of NO, ACE and HDL in patients with coronary artery disease
-
批准号:09670773
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:1997
-
负责人:SAKU Keijiro
-
依托单位:
Quantity, function and genetics of HDL as an indicator of CHD.
-
批准号:07670827
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1995
-
负责人:SAKU Keijiro
-
依托单位:
HDL-apoAI and its isoproteins kinetics in rabbits and gene expressin of apoAI.
-
批准号:02671114
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.02万
-
财政年份:1990
-
负责人:SAKU Keijiro
-
依托单位: